NCT01672983View on ClinicalTrials.gov

A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

ABT-450/ritonavir, ABT-267

ABT-450 (tablet) dosed with ritonavir (capsule), and ABT-267 (tablet)

All Listed Sponsors

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01672983 - A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection | Biotech Hunter | Biotech Hunter